• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不同载脂蛋白组成的高密度脂蛋白颗粒的分布:含载脂蛋白A-I和A-II的颗粒以及含载脂蛋白A-I但不含A-II的颗粒。

Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.

作者信息

Cheung M C, Albers J J

出版信息

J Lipid Res. 1982 Jul;23(5):747-53.

PMID:6811682
Abstract

High density lipoproteins (HDL) were subfractionated by equilibrium CsCl gradient centrifugation of the d 1.063-1.21 g/ml HDL fraction isolated from two men and two women. The various HDL subfractions were analyzed for their apoproteins (apo) A-I, A-II, B, D, and E and the major lipid contents. ApoA-I and A-II were found throughout the density gradient with the maximum concentration between the d 1.105 and 1.120 g/ml fractions. ApoE was found in all HDL fractions with the higher concentration in the lower density fractions. Conversely, the concentration of apoD increased as the density of the HDL fraction increased. Each density subfraction underwent quantitative precipitation with anti-A-I and anti-A-II immunoglobulin. Essentially all A-II in all density subfractions was precipitated with either immunoglobulin. Particles from each density subfraction precipitated with anti-A-II immunoglobulin had an A-I/A-II molar ratio of approximately 2.0 (range 1.9-2.3). However, particles precipitated with anti-A-I immunoglobulin had A-I/A-II molar ratios identical to the A-I/A-II ratio of the subfraction (range 2.1-7.1). The subfractions (d 1.105-1.149 g/ml fractions) with A-I/A-II molar ratios of about 2 had the least proportion of A-I in particles containing A-I but not A-II. Conversely, the subfractions (d 1.063-1.075 g/ml fractions) with the highest A-I/A-II molar ratio had the greatest proportion of apoA-I in particles containing A-I but not A-II. These data indicate that HDL contains at least two types of particles: particles with both A-I and A-II in a 2:1 molar ratio, and particles containing A-I but no A-II. The variation in A-I/A-II ratio observed in different HDL density subfractions was due to the different proportions of these two types of particles.

摘要

通过平衡CsCl梯度离心法对从两名男性和两名女性中分离出的密度为1.063 - 1.21 g/ml的高密度脂蛋白(HDL)组分进行亚组分分离。对各种HDL亚组分进行载脂蛋白(apo)A-I、A-II、B、D和E以及主要脂质成分分析。发现apoA-I和A-II在整个密度梯度中均有分布,在密度为1.105至1.120 g/ml的组分中浓度最高。在所有HDL组分中均发现了apoE,在低密度组分中浓度较高。相反,随着HDL组分密度的增加,apoD的浓度升高。每个密度亚组分都用抗A-I和抗A-II免疫球蛋白进行定量沉淀。基本上所有密度亚组分中的A-II都能用其中任何一种免疫球蛋白沉淀。用抗A-II免疫球蛋白沉淀的每个密度亚组分的颗粒,其A-I/A-II摩尔比约为2.0(范围为1.9 - 2.3)。然而,用抗A-I免疫球蛋白沉淀的颗粒,其A-I/A-II摩尔比与该亚组分的A-I/A-II比值相同(范围为2.1 - 7.1)。A-I/A-II摩尔比约为2的亚组分(密度为1.105 - 1.149 g/ml的组分)在含有A-I但不含A-II的颗粒中A-I的比例最小。相反,A-I/A-II摩尔比最高的亚组分(密度为1.063 - 1.075 g/ml的组分)在含有A-I但不含A-II的颗粒中apoA-I的比例最大。这些数据表明HDL至少包含两种类型的颗粒:A-I和A-II摩尔比为2:1的颗粒,以及含有A-I但不含A-II的颗粒。在不同HDL密度亚组分中观察到的A-I/A-II比值变化是由于这两种类型颗粒的比例不同。

相似文献

1
Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.具有不同载脂蛋白组成的高密度脂蛋白颗粒的分布:含载脂蛋白A-I和A-II的颗粒以及含载脂蛋白A-I但不含A-II的颗粒。
J Lipid Res. 1982 Jul;23(5):747-53.
2
Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios.
J Lipid Res. 1979 Feb;20(2):200-7.
3
Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.酒精性肝炎中的血浆脂蛋白组成:富含载脂蛋白E的高密度脂蛋白的积聚以及部分恢复期间“轻”高密度脂蛋白的优先重现。
J Lipid Res. 1982 May;23(4):556-69.
4
Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.原发性甲状腺功能减退症中高密度脂蛋白的分布及组成变化
Metabolism. 1985 Apr;34(4):345-53. doi: 10.1016/0026-0495(85)90224-0.
5
Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the nonhuman primate.非人灵长类动物中血清淀粉样蛋白A(SAA)诱导导致高密度脂蛋白亚组分分布改变。
J Lipid Res. 1985 Jan;26(1):82-91.
6
Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.甲状腺功能亢进影响人体高密度脂蛋白的分布和载脂蛋白A的组成。
J Clin Endocrinol Metab. 1985 Nov;61(5):882-9. doi: 10.1210/jcem-61-5-882.
7
Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis.通过聚丙烯酰胺梯度凝胶电泳分离的人脂蛋白中的载脂蛋白分布。
J Lipid Res. 1988 May;29(5):573-85.
8
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.烟酸疗法对血浆高密度脂蛋白亚组分分布与组成及载脂蛋白A代谢的影响。
J Clin Invest. 1979 May;63(5):858-67. doi: 10.1172/JCI109385.
9
Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.脂质转运颗粒诱导人高密度脂蛋白转变为载脂蛋白A-I缺乏的低密度颗粒。
J Biol Chem. 1990 Dec 25;265(36):22487-92.
10
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.通过免疫亲和色谱法分离的脂蛋白颗粒的表征。含有A-I和A-II的颗粒以及含有A-I但不含A-II的颗粒。
J Biol Chem. 1984 Oct 10;259(19):12201-9.

引用本文的文献

1
Proteomic Analysis of Follicular Fluid in Polycystic Ovary Syndrome: Insights into Protein Composition and Metabolic Pathway Alterations.多囊卵巢综合征卵泡液的蛋白质组学分析:蛋白组成和代谢途径改变的见解。
Int J Mol Sci. 2024 Nov 1;25(21):11749. doi: 10.3390/ijms252111749.
2
APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1.载脂蛋白A2通过取代驻留载脂蛋白A1的C末端来增加胆固醇向血浆高密度脂蛋白的流出能力。
J Lipid Res. 2024 Dec;65(12):100686. doi: 10.1016/j.jlr.2024.100686. Epub 2024 Oct 28.
3
High-Density Lipoprotein Modifications: Causes and Functional Consequences in Type 2 Diabetes Mellitus.
高密度脂蛋白修饰:2 型糖尿病中的病因和功能后果。
Cells. 2024 Jun 27;13(13):1113. doi: 10.3390/cells13131113.
4
Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics.通过体内示踪动力学了解 HDL 代谢和生物学。
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):76-88. doi: 10.1161/ATVBAHA.123.319742. Epub 2023 Nov 30.
5
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.高密度脂蛋白功能与动脉粥样硬化:活性二羰基化合物作为有前途的治疗靶点。
Circ Res. 2023 May 26;132(11):1521-1545. doi: 10.1161/CIRCRESAHA.123.321563. Epub 2023 May 25.
6
Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy.我们对长链非编码RNA在正常肝功能、疾病及恶性肿瘤中所起作用的新认识。
JHEP Rep. 2020 Sep 3;3(1):100177. doi: 10.1016/j.jhepr.2020.100177. eCollection 2021 Feb.
7
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.载脂蛋白定义的高密度脂蛋白亚类与 4 项前瞻性研究中的冠心病风险差异。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2714-2727. doi: 10.1161/ATVBAHA.120.314609. Epub 2020 Sep 10.
8
Deepening our understanding of HDL proteome.深入了解高密度脂蛋白蛋白质组。
Expert Rev Proteomics. 2019 Sep;16(9):749-760. doi: 10.1080/14789450.2019.1650645. Epub 2019 Aug 27.
9
From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.从高密度脂蛋白胆固醇到功能测量:心血管疾病中高密度脂蛋白功能检测方法的发展前景。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):487-499. doi: 10.1161/ATVBAHA.117.307025. Epub 2018 Jan 25.
10
ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.载脂蛋白 A-I/A-II-HDL 与载脂蛋白 B 脂质蛋白呈正相关,是潜在的致动脉粥样硬化指标。
Lipids Health Dis. 2017 Nov 29;16(1):225. doi: 10.1186/s12944-017-0619-y.